These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3391114)

  • 21. [Effect of clavulanic acid/ticarcillin on severe infections accompanying hematological diseases].
    Urabe A; Takaku F; Kitagawa S; Miura Y; Dan K; Nomura T; Masuda M; Mizoguchi H; Yano T; Toyama K
    Jpn J Antibiot; 1987 Apr; 40(4):749-58. PubMed ID: 3613092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic-induced recurring interstitial nephritis.
    Sakarcan A; Marcille R; Stallworth J
    Pediatr Nephrol; 2002 Jan; 17(1):50-1. PubMed ID: 11793135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noncomparative trial of ticarcillin plus clavulanic acid in skin and soft tissue infections.
    LeFrock JL; Johnson ES; Smith LG; Rosenberg E
    Am J Med; 1985 Nov; 79(5B):122-5. PubMed ID: 3907339
    [No Abstract]   [Full Text] [Related]  

  • 24. Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer.
    Shenep JL; Hughes WT; Roberson PK; Blankenship KR; Baker DK; Meyer WH; Gigliotti F; Sixbey JW; Santana VM; Feldman S
    N Engl J Med; 1988 Oct; 319(16):1053-8. PubMed ID: 3050517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ticarcillin/clavulanate for the treatment of female genital tract infections. Efficacy, safety and comparative microbiology.
    McGregor JA
    J Reprod Med; 1990 Mar; 35(3 Suppl):333-8. PubMed ID: 2319515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ticarcillin plus clavulanic acid (Timentin)--further UK trial results.
    Tehan S; Horobin J; Gordonsmith R; McLatchie GR
    Br J Clin Pract; 1988 Jan; 42(1):8-16. PubMed ID: 3058192
    [No Abstract]   [Full Text] [Related]  

  • 27. Intrahepatic cholestasis due to ticarcillin-clavulanate.
    Sweet JM; Jones MP
    Am J Gastroenterol; 1995 Apr; 90(4):675-6. PubMed ID: 7717345
    [No Abstract]   [Full Text] [Related]  

  • 28. Overview of bacterial infections of the skin and soft tissue and clinical experience with ticarcillin plus clavulanate potassium in their treatment.
    Pankey GA; Katner HP; Valainis GT; Clarkson MJ; Cortez LM; Dalovisio JR
    Am J Med; 1985 Nov; 79(5B):106-15. PubMed ID: 4073076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ticarcillin/clavulanate in severe infections in patients with varying renal function.
    Dalet F; del Rio G; Torrellas A
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():131-9. PubMed ID: 2606815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic experience with ticarcillin disodium plus potassium clavulanate in the Federal Republic of Germany--results of a multicentre-study.
    Heilmann HD
    Int J Clin Pharmacol Res; 1987; 7(3):233-7. PubMed ID: 3596864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Failure to adopt new interpretive criteria for ticarcillin-clavulanic acid could prove fatal.
    Sanders CC; Sanders WE; Thomson KS; Cavalieri SJ
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1343-4. PubMed ID: 1416837
    [No Abstract]   [Full Text] [Related]  

  • 32. Timentin versus piperacillin in the treatment of hospitalized patients with urinary tract infections.
    Cox CE
    J Antimicrob Chemother; 1986 May; 17 Suppl C():93-6. PubMed ID: 3636340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ticarcillin-induced cystitis. Cross-reactivity with related penicillins.
    Marx CM; Alpert SE
    Am J Dis Child; 1984 Jul; 138(7):670-2. PubMed ID: 6731385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ticarcillin associated hypokalemia.
    Nanji AA; Lindsay J
    Clin Biochem; 1982 Apr; 15(2):118-9. PubMed ID: 7094288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A controlled study of ticarcillin plus clavulanic acid versus piperacillin as empiric therapy for fever in the immunocompromised host.
    Williams ME; Harman C; Scheld M; Hess CE; Donowitz GR
    Am J Med; 1985 Nov; 79(5B):67-72. PubMed ID: 3907343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The clinical efficacy of ticarcillin/clavulanate in severe pneumonia].
    Iakovlev SV; Dvoretskiĭ LI; Shakhova TV
    Antibiot Khimioter; 2000; 45(3):30-4. PubMed ID: 10768064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and effectiveness of ticarcillin plus clavulanic acid in the treatment of community-acquired acute pyelonephritis in adult women.
    Sanders CV; Marier RL; Aldridge KE; Derks FW; Martin DH
    Am J Med; 1985 Nov; 79(5B):96-100. PubMed ID: 3907345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infection in women. Clinical experience with beta-lactamase inhibitors.
    Holloway WJ
    J Reprod Med; 1988 Jun; 33(6 Suppl):595-7. PubMed ID: 3294405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of ticarcillin/clavulanate potassium in the treatment of obstetric and gynecologic infections.
    Martens MG
    Hosp Formul; 1990 Feb; 25(2):186-8, 192. PubMed ID: 10113105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of ticarcillin plus clavulanic acid in the treatment of infections of soft tissue, bone, and joint.
    Johnson CC; Reinhardt JF; Wallace SL; Terpenning MS; Helsel CL; Mulligan ME; Finegold SM; George WL
    Am J Med; 1985 Nov; 79(5B):136-40. PubMed ID: 4073081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.